Effect of esophageal body recoil on clinical outcomes in non‐spastic achalasia

Background Despite the established efficacy of achalasia treatments on symptomatic outcomes, there are limited data evaluating the treatment effect on esophageal dilatation. This study aimed to assess the effect achalasia treatment on esophageal dilatation and the effect of esophageal width reductio...

Full description

Saved in:
Bibliographic Details
Published in:Neurogastroenterology and motility 2024-06, Vol.36 (6), p.e14785-n/a
Main Authors: Farina, Domenico A., Olson, Dylan A., Carlson, Dustin A., Kahrilas, Peter J., Vespa, Edoardo, Koop, Andree H., Arroyo, Yadis, Goudie, Eric, Pandolfino, John E.
Format: Article
Language:English
Subjects:
Achalasia
Barium
Clinical outcomes
dysphagia
Esophagus
impedance
Mechanical properties
motility
Patients
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Despite the established efficacy of achalasia treatments on symptomatic outcomes, there are limited data evaluating the treatment effect on esophageal dilatation. This study aimed to assess the effect achalasia treatment on esophageal dilatation and the effect of esophageal width reduction (“recoil”) on clinical outcomes. Methods Patients with type I or type II achalasia that completed high‐resolution manometry (HRM), functional lumen imaging probe (FLIP), and timed barium esophagram (TBE) pre and post treatment were included. Esophageal width was measured using TBE. Focused subgroup analysis was performed on patients with normal posttreatment EGJ opening on FLIP. Good clinical outcomes were defined as barium column height of
ISSN:1350-1925
1365-2982
DOI:10.1111/nmo.14785